KALV - Kalvista Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KALV is currently covered by 4 analysts with an average price target of $35.67. This is a potential upside of $19.34 (32.11%) from yesterday's end of day stock price of $27.

Kalvista Pharmaceuticals's activity chart (see below) currently has 83 price targets and 77 ratings on display. The stock rating distribution of KALV is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 46.33% with an average time for these price targets to be met of 402.64 days.

Highest price target for KALV is $42, Lowest price target is $28, average price target is $35.67.

Most recent stock forecast was given by from NEEDHAM on 30-Apr-2026. First documented stock forecast 04-May-2015.

Best performing analysts who are covering KALV - Kalvista Pharmaceuticals:

Paul Matteis Zegbeh Jallah Dae Gon Ha Serge Belanger Charles Duncan Jonathan Wolleben

Currently out of the existing stock ratings of KALV, 10 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Mar-2019

$35

4 months 17 days ago
(30-Apr-2026)

5/25 (20%)

$18.2 (108.33%)

677

Buy Since 31-Jan-2025

$28

$1 (3.70%)

$28

5 months 21 days ago
(26-Mar-2026)

5/8 (62.5%)

$9.05 (47.76%)

369

Buy Since 15-Oct-2018

$42

$15 (55.56%)

$39

5 months 21 days ago
(26-Mar-2026)

2/8 (25%)

$23.05 (121.64%)

670

Buy Since 15-Jun-2020

$37

$10 (37.04%)

$27

8 months 7 days ago
(09-Jan-2026)

13/14 (92.86%)

$20.2 (120.24%)

452

Buy Since 18-Dec-2024

$36

$9 (33.33%)

$37

1 years 5 days ago
(11-Sep-2025)

1/3 (33.33%)

$21.19 (143.08%)

497

Show more analysts

Please expand the browser size to see the chart

What is KALV (Kalvista Pharmaceuticals) average time for price targets to be met?

On average it took 403 days for the stock forecasts to be reached, with an average price target met ratio of 46.33%.

Which analyst most recently updated their price target on KALV (Kalvista Pharmaceuticals)?

Which analyst has the most public recommendations on KALV (Kalvista Pharmaceuticals)?

has 0 price targets and 0 ratings on KALV

Which analyst is the currently most bullish on KALV (Kalvista Pharmaceuticals)?

Jason Gerberry with the highest potential upside of $207

Which analyst is the currently most reserved on KALV (Kalvista Pharmaceuticals)?

Joseph Schwartz with the lowest potential downside of -$7

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?